
    
      The study will include three phases: screening, treatment and follow-up.

      Screening: This phase will last a maximum of 7 days and subjects eligibility will be
      evaluated after informed consent signature.

      Treatment: Subjects are randomly assigned to treatment and will be treated for 7 days. Daily
      oral ulcer area and symptoms were recorded during the treatment period. A randomization visit
      will take place on day 0 and an end-of-treatment visit will take place between day 6 and 8.

      Follow-up: 28 days after the end of treatment. Efficacy of treatment was evaluated by the
      oral ulcer remission or decreasing.
    
  